How does FDA regulate tissue products? What safeguards are in place for recipients?
FDA regulates human cells or tissues intended for implantation, transplantation, infusion, or transfer into human recipients. These are referred to as human cells, tissue, and cellular and tissue-based products, or HCT/Ps. Examples of HCT/Ps include
- dura mater
- heart valves
- cell-based products
- reproductive tissues including oocytes and semen
FDA focuses on three general areas of regulation:
- limiting the risk that a communicable disease may be transferred from a cell or tissue donor to the recipient
- establishing manufacturing practices that minimize the risk that cell or tissue products will be contaminated
- requiring cells and tissues that present greater risks due to their processing or their use to demonstrate safety and effectiveness
FDA does not regulate the transplantation of human organs containing blood vessels (such as kidney, liver, heart, lung or pancreas). The Health Resources Services Administration oversees human organs.
- FDA Basic Video: Norman Baylor Discusses Vaccines (Video)
- Webinar on FDA’s Safety Monitoring of Approved Vaccines
- FDA Webinar on Safety of the Blood Supply
- FDA Webinar on Protecting Your Child's Health Through Safe and Effective Vaccines
- What are stem cells? How are they regulated?
- What is thimerosal? Is it safe when used in some vaccines?
- How can I get my name removed from a donor deferral list?
- What is a biological product?
- How does FDA regulate tissue products? What safeguards are in place for recipients?
- How do I know if I’m eligible to donate blood?
- How do I report an adverse event related to a vaccine?
- What is the Vaccine Adverse Event Reporting System (VAERS)?
- How does FDA assess the safety of vaccines?
- What is the approval process for a biological product?
How helpful was this information?